Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects

Abstract

Background: Arterial stiffening is an independent predictor for cardiovascular mortality. Preliminary studies have shown that arterial calcification may have an impact on increased vascular stiffness. However, there are limited data about the role of calcification inhibitor osteoprotegerin (OPG) as an independent predictor for arterial stiffness in patients with peripheral arterial disease (PAD) and in healthy subjects. The aim of this study was to evaluate the association between OPG and arterial stiffness parameters in patients with PAD and in healthy subjects. Methods: We studied 69 men with PAD (age 63 ± 7 years) and 68 healthy subjects (age 54 ± 8 years). Serum OPG and oxidized low-density lipoprotein (oxLDL) were measured using the enzyme-linked immunosorbent assay method. Radial and aortic pulse wave velocity (aPWV) and augmentation index (AIx) were determined by applanation tonometry. Results: The OPG (5.4 ± 1.7 vs. 4.4 ± 1.1pmol/l; P <0.001) and aPWV (10.1 2.5 vs. 7.6 1.6m/s; P 0.001) were different for the patients and for the controls. There was a linear relationship between OPG and aPWV in patients with PAD (R = 0.37; P = 0.003) and in healthy individuals (R = 0.40; P = 0.001). In multiple regression models after adjustment for potential confounders, OPG was independently associated with aPWV in the patients (R2 = 0.47; P <0.0001) and in the controls (R2 = 0.44; P ±0.0001). The AIx or radial PWV was not correlated with OPG for either group. Conclusion The independent association between OPG and aPWV in patients with PAD and in controls suggests that the calcification inhibitor OPG may influence aortic stiffening in atherosclerosis and in clinically healthy subjects. © 2010 American Journal of Hypertension, Ltd.